{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T14:01:34Z","timestamp":1762956094104,"version":"3.37.3"},"reference-count":214,"publisher":"Bentham Science Publishers Ltd.","issue":"6","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CNSNDDT"],"published-print":{"date-parts":[[2019,8,30]]},"abstract":"<jats:sec><jats:title>:<\/jats:title><jats:p>Cerebral brain hemorrhage is associated with the highest mortality and morbidity despite only constituting approximately 10-15% of all strokes classified into intracerebral and intraventricular hemorrhage where most of the patients suffer from impairment in memory, weakness or paralysis in arms or legs, headache, fatigue, gait abnormality and cognitive dysfunctions. Understanding molecular pathology and finding the worsening cause of hemorrhage will lead to explore the therapeutic interventions that could prevent and cure the disease. Mitochondrial ETC-complexes dysfunction has been found to increase neuroinflammatory cytokines, oxidative free radicals, excitotoxicity, neurotransmitter and energy imbalance that are the key neuropathological hallmarks of cerebral hemorrhage. Coenzyme Q10 (CoQ10), as a part of the mitochondrial respiratory chain can effectively restore these neuronal dysfunctions by preventing the opening of mitochondrial membrane transition pore, thereby counteracting cell death events as well as exerts an anti-inflammatory effect by influencing the expression of NF-kB1 dependent genes thus preventing the neuroinflammation and energy restoration. Due to behavior and biochemical heterogeneity in post cerebral brain hemorrhagic pattern different preclinical autologous blood injection models are required to precisely investigate the forthcoming therapeutic strategies. Despite emerging pre-clinical research and resultant large clinical trials for promising symptomatic treatments, there are very less pharmacological interventions demonstrated to improve post operative condition of patients where intensive care is required. Therefore, in current review, we explore the disease pattern, clinical and pre-clinical interventions under investigation and neuroprotective methodologies of CoQ10 precursors to ameliorate post brain hemorrhagic conditions.<\/jats:p><\/jats:sec>","DOI":"10.2174\/1871527318666190610101144","type":"journal-article","created":{"date-parts":[[2019,6,12]],"date-time":"2019-06-12T09:34:00Z","timestamp":1560332040000},"page":"446-465","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Neuroprotective Methodologies of Co-Enzyme Q10 Mediated Brain Hemorrhagic Treatment: Clinical and Pre-Clinical Findings"],"prefix":"10.2174","volume":"18","author":[{"given":"Kajal","family":"Rajdev","sequence":"first","affiliation":[{"name":"Department of Pharmacology, ISF College of Pharmacy, Moga-142001, Punjab, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sidharth","family":"Mehan","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, ISF College of Pharmacy, Moga-142001, Punjab, India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.emc.2012.06.003","volume":"30","author":"Caceres J.A.","year":"2012","unstructured":"Caceres J.A.; Goldstein J.N.; Intracranial hemorrhage. Emerg Med Clin North Am 2012,30(3),771-794","journal-title":"Emerg Med Clin North Am"},{"key":"ref=2","first-page":"128","volume":"15","year":"2013","unstructured":"Stroke epidemiology and stroke care services in India 2013,15(3),128-34"},{"key":"ref=3","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.neuroscience.2014.05.001","volume":"272","author":"Marinkovic I.","year":"2014","unstructured":"Marinkovic I.; Strbian D.; Mattila O.S.; Abo-Ramadan U.; Tatlisumak T.; A novel combined model of intracerebral and intraventricular hemorrhage using autologous blood-injection in rats. Neuroscience 2014,272,286-294","journal-title":"Neuroscience"},{"key":"ref=4","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1136\/svn-2015-000003","volume":"1","author":"Bu Y.","year":"2016","unstructured":"Bu Y.; Chen M.; Gao T.; Wang X.; Li X.; Gao F.; Mechanisms of hydrocephalus after intraventricular haemorrhage in adults. Stroke Vasc Neurol 2016,1(1),23-27","journal-title":"Stroke Vasc Neurol"},{"key":"ref=5","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1007\/s11883-012-0252-1","volume":"14","author":"Ikram M.A.","year":"2012","unstructured":"Ikram M.A.; Wieberdink R.G.; Koudstaal P.J.; International epidemiology of intracerebral hemorrhage. Curr Atheroscler Rep 2012,14(4),300-306","journal-title":"Curr Atheroscler Rep"},{"key":"ref=6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000437109","volume":"Vol. 37","author":"Poon M.T.","year":"2016","unstructured":"Poon M.T.; Bell S.M.; Salman R.A.S.; New Insights in Intracerebral Hemorrhage 2016,Vol. 37,1-12","journal-title":"New Insights in Intracerebral Hemorrhage"},{"key":"ref=7","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1161\/01.STR.14.4.501","volume":"14","author":"Nedergaard M.","year":"1983","unstructured":"Nedergaard M.; Klinken L.; Paulson O.B.; Secondary brain stem hemorrhage in stroke. Stroke 1983,14(4),501-505","journal-title":"Stroke"},{"key":"ref=8","doi-asserted-by":"crossref","first-page":"3","DOI":"10.5853\/jos.2016.00864","volume":"19","author":"An S.J.","year":"2017","unstructured":"An S.J.; Kim T.J.; Yoon B.W.; Epidemiology, risk factors, and clinical features of intracerebral hemorrhage: An update. J Stroke 2017,19(1),3-10","journal-title":"J Stroke"},{"key":"ref=9","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1212\/01.WNL.0000063316.47591.B4","volume":"60","author":"Vespa P.M.","year":"2003","unstructured":"Vespa P.M.; O\u2019Phelan K.; Shah M.; Acute seizures after intracerebral hemorrhage: A factor in progressive midline shift and outcome. Neurology 2003,60(9),1441-1446","journal-title":"Neurology"},{"key":"ref=10","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S1042-3680(18)30643-0","volume":"3","author":"Wityk R.J.","year":"1992","unstructured":"Wityk R.J.; Caplan L.R.; Hypertensive intracerebral hemorrhage. Epidemiology and clinical pathology. Neurosurg Clin N Am 1992,3(3),521-532","journal-title":"Neurosurg Clin N Am"},{"key":"ref=11","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1177\/1941875211409050","volume":"1","author":"Aguilar M.I.","year":"2011","unstructured":"Aguilar M.I.; Brott T.G.; Update in intracerebral hemorrhage. Neurohospitalist 2011,1(3),148-159","journal-title":"Neurohospitalist"},{"key":"ref=12","doi-asserted-by":"crossref","first-page":"23","DOI":"10.2340\/16501977-1229","volume":"46","author":"Wallmark S.","year":"2014","unstructured":"Wallmark S.; Ronne-Engstr\u00f6m E.; Lundstr\u00f6m E.; Prevalence of spasticity after aneurysmal subarachnoid haemorrhage. J Rehabil Med 2014,46(1),23-27","journal-title":"J Rehabil Med"},{"key":"ref=13","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1600-0404.2005.00449.x","volume":"112","author":"Egge A.","year":"2005","unstructured":"Egge A.; Waterloo K.; Sj\u00f8holm H.; Outcome 1 year after aneurysmal subarachnoid hemorrhage: Relation between cognitive performance and neuroimaging. Acta Neurol Scand 2005,112(2),76-80","journal-title":"Acta Neurol Scand"},{"key":"ref=14","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1212\/01.WNL.0000035748.91128.C2","volume":"59","author":"Mayer S.A.","year":"2002","unstructured":"Mayer S.A.; Kreiter K.T.; Copeland D.; Global and domain-specific cognitive impairment and outcome after subarachnoid hemorrhage. Neurology 2002,59(11),1750-1758","journal-title":"Neurology"},{"key":"ref=15","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1097\/01.nrl.0000178757.68551.26","volume":"11","author":"Badjatia N.","year":"2005","unstructured":"Badjatia N.; Rosand J.; Intracerebral hemorrhage. Neurologist 2005,11(6),311-324","journal-title":"Neurologist"},{"key":"ref=16","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1002\/ana.22134","volume":"68","author":"Biffi A.","year":"2010","unstructured":"Biffi A.; Sonni A.; Anderson C.D.; Variants at APOE influence risk of deep and lobar intracerebral hemorrhage. Ann Neurol 2010,68(6),934-943","journal-title":"Ann Neurol"},{"key":"ref=17","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1055\/s-0030-1268866","volume":"30","author":"Flaherty M.L.","year":"2010","unstructured":"Flaherty M.L.; Anticoagulant-associated intracerebral hemorrhage. Semin Neurol 2010,30(05),565-572","journal-title":"Semin Neurol"},{"key":"ref=18","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/B978-0-12-803058-5.00120-X","author":"Sweis R.","year":"2017","unstructured":"Sweis R.; Biller J.; Toxicity\/substance abusePrimer on cerebrovascular diseases 2017,614-622","journal-title":"Toxicity\/substance abusePrimer on cerebrovascular diseases"},{"key":"ref=19","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ijscr.2016.10.046","volume":"29","author":"Hegde A.","year":"2016","unstructured":"Hegde A.; Nair R.; Upadhyaya S.; Spontaneous intracerebral hemorrhage in hemophiliacs-A treatment dilemma. Int J Surg Case Rep 2016,29,17-19","journal-title":"Int J Surg Case Rep"},{"key":"ref=20","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1161\/01.STR.31.11.2665","volume":"31","author":"Roob G.","year":"2000","unstructured":"Roob G.; Lechner A.; Schmidt R.; Flooh E.; Hartung H.P.; Fazekas F.; Frequency and location of microbleeds in patients with primary intracerebral hemorrhage. Stroke 2000,31(11),2665-2669","journal-title":"Stroke"},{"key":"ref=21","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1161\/01.STR.30.4.905","volume":"30","author":"Broderick J.P.","year":"1999","unstructured":"Broderick J.P.; Adams H.P.; Barsan W.; Guidelines for the management of spontaneous intracerebral hemorrhage: A statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke 1999,30(4),905-915","journal-title":"Stroke"},{"key":"ref=22","author":"Neil L.","year":"2016","unstructured":"Neil L.; Brain hemorrhage: Causes, symptoms, treatments 2016","journal-title":"Brain hemorrhage: Causes, symptoms, treatments"},{"key":"ref=23","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.jocn.2004.12.012","volume":"13","author":"Sutherland G.R.","year":"2006","unstructured":"Sutherland G.R.; Auer R.N.; Primary intracerebral hemorrhage. J Clin Neurosci 2006,13(5),511-517","journal-title":"J Clin Neurosci"},{"key":"ref=24","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1097\/00006123-199807000-00013","volume":"43","author":"Qureshi A.I.","year":"1998","unstructured":"Qureshi A.I.; Suarez J.I.; Parekh P.D.; Risk factors for multiple intracranial aneurysms. Neurosurgery 1998,43(1),22-26","journal-title":"Neurosurgery"},{"key":"ref=25","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1212\/WNL.46.5.1291","volume":"46","author":"Nolte K.B.","year":"1996","unstructured":"Nolte K.B.; Brass L.M.; Fletterick C.F.; Intracranial hemorrhage associated with cocaine abuse: A prospective autopsy study. Neurology 1996,46(5),1291-1296","journal-title":"Neurology"},{"key":"ref=26","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1093\/brain\/awx047","volume":"140","author":"Charidimou A.","year":"2017","unstructured":"Charidimou A.; Boulouis G.; Gurol M.E.; Emerging concepts in sporadic cerebral amyloid angiopathy. Brain 2017,140(7),1829-1850","journal-title":"Brain"},{"key":"ref=27","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/0022-510X(93)90317-R","volume":"116","author":"Itoh Y.","year":"1993","unstructured":"Itoh Y.; Yamada M.; Hayakawa M.; Otomo E.; Miyatake T.; Cerebral amyloid angiopathy: A significant cause of cerebellar as well as lobar cerebral hemorrhage in the elderly. J Neurol Sci 1993,116(2),135-141","journal-title":"J Neurol Sci"},{"year":"2016","author":"Findlay J.M.","key":"ref=28","unstructured":"Findlay J.M.; James C. Grotta, Joseph P. Broderick, Eng H. Lo, Ralph L. Sacco, Gregory W. Albers, Scott E. Kasner, A. David Mendelow, Lawrence K.S. Wong, Eds; Stroke (Sixth Edition)2016"},{"key":"ref=29","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1212\/01.wnl.0000210524.68507.87","volume":"66","author":"Stapf C.","year":"2006","unstructured":"Stapf C.; Mast H.; Sciacca R.R.; Predictors of hemorrhage in patients with untreated brain arteriovenous malformation. Neurology 2006,66(9),1350-1355","journal-title":"Neurology"},{"key":"ref=30","first-page":"249","volume":"12","author":"Singleton T.C.","year":"2012","unstructured":"Singleton T.C.; Keane M.; Diagnostic and therapeutic challenges of intracranial hemorrhage in neonates with congenital hemophilia: A case report and review. Ochsner J 2012,12(3),249-253","journal-title":"Ochsner J"},{"key":"ref=31","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1161\/STROKEAHA.110.596718","volume":"42","author":"Aronowski J.","year":"2011","unstructured":"Aronowski J.; Zhao X.; Molecular pathophysiology of cerebral hemorrhage: Secondary brain injury. Stroke 2011,42(6),1781-1786","journal-title":"Stroke"},{"key":"ref=32","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1179\/016164105X25225","volume":"27","author":"Aronowski J.","year":"2005","unstructured":"Aronowski J.; Hall C.E.; New horizons for primary intracerebral hemorrhage treatment: Experience from preclinical studies. Neurol Res 2005,27(3),268-279","journal-title":"Neurol Res"},{"key":"ref=33","doi-asserted-by":"crossref","first-page":"205","DOI":"10.2174\/1871527318666190204102604","volume":"18","author":"Li L.","year":"2019","unstructured":"Li L.; Wang P.; Zhao H.; Luo Y.; Noncoding RNAs and intracerebral hemorrhage. CNS Neurol Disord Drug Targets 2019,18(3),205-211","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"ref=34","author":"Chakrabarty A.","year":"2008","unstructured":"Chakrabarty A.; Pathology of intracerebral haemorrhage 2008","journal-title":"Pathology of intracerebral haemorrhage"},{"key":"ref=35","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1016\/S0140-6736(09)60371-8","volume":"373","author":"Qureshi A.I.","year":"2009","unstructured":"Qureshi A.I.; Mendelow A.D.; Hanley D.F.; Intracerebral haemorrhage. Lancet 2009,373(9675),1632-1644","journal-title":"Lancet"},{"key":"ref=36","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1042\/bj2560861","volume":"256","author":"Gutteridge J.M.C.","year":"1988","unstructured":"Gutteridge J.M.C.; Smith A.; Antioxidant protection by haemopexin of haem-stimulated lipid peroxidation. Biochem J 1988,256(3),861-865","journal-title":"Biochem J"},{"key":"ref=37","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1136\/svn-2018-000205","volume":"4","author":"Wan J.","year":"2019","unstructured":"Wan J.; Ren H.; Wang J.; Iron toxicity, lipid peroxidation and ferroptosis after intracerebral haemorrhage. Stroke Vasc Neurol 2019,4(2),93-95","journal-title":"Stroke Vasc Neurol"},{"key":"ref=38","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1136\/svn-2016-000042","volume":"1","author":"Garton T.","year":"2016","unstructured":"Garton T.; Keep R.F.; Hua Y.; Xi G.; Brain iron overload following intracranial haemorrhage. Stroke Vasc Neurol 2016,1(4),172-184","journal-title":"Stroke Vasc Neurol"},{"key":"ref=39","doi-asserted-by":"crossref","first-page":"3587","DOI":"10.1161\/STROKEAHA.111.623926","volume":"42","author":"Zhao F.","year":"2011","unstructured":"Zhao F.; Hua Y.; He Y.; Keep R.F.; Xi G.; Minocycline-induced attenuation of iron overload and brain injury after experimental intracerebral hemorrhage. Stroke 2011,42(12),3587-3593","journal-title":"Stroke"},{"key":"ref=40","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/S1474-4422(14)70117-6","volume":"13","author":"Ward R.J.","year":"2014","unstructured":"Ward R.J.; Zucca F.A.; Duyn J.H.; Crichton R.R.; Zecca L.; The role of iron in brain ageing and neurodegenerative disorders. Lancet Neurol 2014,13(10),1045-1060","journal-title":"Lancet Neurol"},{"key":"ref=41","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1016\/j.pmrj.2011.05.007","volume":"3","author":"Whyte E.","year":"2011","unstructured":"Whyte E.; Skidmore E.; Aizenstein H.; Ricker J.; Butters M.; Cognitive impairment in acquired brain injury: A predictor of rehabilitation outcomes and an opportunity for novel interventions. PM R 2011,3(6)(Suppl. 1),S45-S51","journal-title":"PM R"},{"key":"ref=42","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1001\/jamaneurol.2016.0955","volume":"73","author":"Biffi A.","year":"2016","unstructured":"Biffi A.; Bailey D.; Anderson C.D.; Risk factors associated with early vs delayed dementia after intracerebral hemorrhage. JAMA Neurol 2016,73(8),969-976","journal-title":"JAMA Neurol"},{"key":"ref=43","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1001\/jamaneurol.2016.1538","volume":"73","author":"Gottesman R.F.","year":"2016","unstructured":"Gottesman R.F.; Dementia after intracerebral hemorrhage. JAMA Neurol 2016,73(8),916-917","journal-title":"JAMA Neurol"},{"key":"ref=44","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1126\/science.8389057","volume":"260","author":"Frey U.","year":"1993","unstructured":"Frey U.; Huang Y.Y.; Kandel E.R.; Effects of cAMP simulate a late stage of LTP in hippocampal CA1 neurons. Science 1993,260(5114),1661-1664","journal-title":"Science"},{"key":"ref=45","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.nlm.2005.03.002","volume":"84","author":"Cammarota M.","year":"2005","unstructured":"Cammarota M.; Bevilaqua L.R.; Rossato J.I.; Ramirez M.; Medina J.H.; Izquierdo I.; Relationship between short- and long-term memory and short- and long-term extinction. Neurobiol Learn Mem 2005,84(1),25-32","journal-title":"Neurobiol Learn Mem"},{"key":"ref=46","doi-asserted-by":"crossref","first-page":"163","DOI":"10.2147\/JEP.S35326","volume":"4","author":"Colucci L.","year":"2012","unstructured":"Colucci L.; Bosco M.; Rosario Ziello A.; Rea R.; Amenta F.; Fasanaro A.M.; Effectiveness of nootropic drugs with cholinergic activity in treatment of cognitive deficit: A review. J Exp Pharmacol 2012,4,163-172","journal-title":"J Exp Pharmacol"},{"key":"ref=47","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2174\/1570159X13666150716165726","volume":"14","author":"Ferreira-Vieira T.H.","year":"2016","unstructured":"Ferreira-Vieira T.H.; Guimaraes I.M.; Silva F.R.; Ribeiro F.M.; Alzheimer\u2019s disease: Targeting the cholinergic system. Curr Neuropharmacol 2016,14(1),101-115","journal-title":"Curr Neuropharmacol"},{"key":"ref=48","doi-asserted-by":"crossref","first-page":"176","DOI":"10.2174\/1871527315666161213110518","volume":"16","author":"Cikankova T.","year":"2017","unstructured":"Cikankova T.; Sigitova E.; Zverova M.; Mitochondrial dysfunctions in bipolar disorder: Effect of the disease and pharmacotherapy. CNS Neurol Disord Drug Targets 2017,16(2),176-186","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"ref=49","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1089\/neu.2014.3445","volume":"32","author":"Shin S.S.","year":"2015","unstructured":"Shin S.S.; Dixon C.E.; Alterations in cholinergic pathways and therapeutic strategies targeting cholinergic system after traumatic brain injury. J Neurotrauma 2015,32(19),1429-1440","journal-title":"J Neurotrauma"},{"key":"ref=50","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1054\/jocn.2001.0916","volume":"8","author":"Reilly P.L.","year":"2001","unstructured":"Reilly P.L.; Brain injury: The pathophysiology of the first hours.\u2018Talk and Die revisited\u2019. J Clin Neurosci 2001,8(5),398-403","journal-title":"J Clin Neurosci"},{"key":"ref=51","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1097\/01.CCM.0000063047.63862.99","volume":"31","author":"Qureshi A.I.","year":"2003","unstructured":"Qureshi A.I.; Ali Z.; Suri M.F.; Extracellular glutamate and other amino acids in experimental intracerebral hemorrhage: An in vivo microdialysis study. Crit Care Med 2003,31(5),1482-1489","journal-title":"Crit Care Med"},{"key":"ref=52","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1097\/01.CCM.0000063047.63862.99","volume":"31","author":"Qureshi A.I.","year":"2003","unstructured":"Qureshi A.I.; Ali Z.; Suri M.F.; Extracellular glutamate and other amino acids in experimental intracerebral hemorrhage: An in vivo microdialysis study. Crit Care Med 2003,31(5),1482-1489","journal-title":"Crit Care Med"},{"key":"ref=53","doi-asserted-by":"crossref","first-page":"6125","DOI":"10.1523\/JNEUROSCI.16-19-06125.1996","volume":"16","author":"Schinder A.F.","year":"1996","unstructured":"Schinder A.F.; Olson E.C.; Spitzer N.C.; Montal M.; Mitochondrial dysfunction is a primary event in glutamate neurotoxicity. J Neurosci 1996,16(19),6125-6133","journal-title":"J Neurosci"},{"key":"ref=54","doi-asserted-by":"crossref","first-page":"863","DOI":"10.2217\/fca.12.58","volume":"8","author":"Webster K.A.","year":"2012","unstructured":"Webster K.A.; Mitochondrial membrane permeabilization and cell death during myocardial infarction: Roles of calcium and reactive oxygen species. Future Cardiol 2012,8(6),863-884","journal-title":"Future Cardiol"},{"key":"ref=55","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.bbabio.2009.02.021","volume":"1787","author":"Celsi F.","year":"2009","unstructured":"Celsi F.; Pizzo P.; Brini M.; Mitochondria, calcium and cell death: A deadly triad in neurodegeneration. Biochimica et Biophysica Acta (BBA)-. Bioenergetics 2009,1787(5),335-344","journal-title":"Bioenergetics"},{"key":"ref=56","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1002\/ana.410190202","volume":"19","author":"Rothman S.M.","year":"1986","unstructured":"Rothman S.M.; Olney J.W.; Glutamate and the pathophysiology of hypoxic--ischemic brain damage. Ann Neurol 1986,19(2),105-111","journal-title":"Ann Neurol"},{"key":"ref=57","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1053\/jscd.2000.18908","volume":"9","author":"D\u00e1valos A.","year":"2000","unstructured":"D\u00e1valos A.; Shuaib A.; Wahlgren N.G.; Neurotransmitters and pathophysiology of stroke: Evidence for the release of glutamate and other transmitters\/mediators in animals and humans. J Stroke Cerebrovasc Dis 2000,9(6 Pt 2),2-8","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"ref=58","doi-asserted-by":"crossref","first-page":"696","DOI":"10.2174\/1871527317666180816100203","volume":"17","author":"Kumar A.","year":"2018","unstructured":"Kumar A.; Dhawan A.; Kadam A.; Shinde A.; Autophagy and mitochondria: Targets in neurodegenerative disorders. CNS Neurol Disord Drug Targets 2018,17(9),696-705","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"ref=59","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1161\/01.STR.0000240674.99945.4e","volume":"37","author":"Kim-Han J.S.","year":"2006","unstructured":"Kim-Han J.S.; Kopp S.J.; Dugan L.L.; Diringer M.N.; Perihematomal mitochondrial dysfunction after intracerebral hemorrhage. Stroke 2006,37(10),2457-2462","journal-title":"Stroke"},{"key":"ref=60","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1097\/00004647-200107000-00005","volume":"21","author":"Zazulia A.R.","year":"2001","unstructured":"Zazulia A.R.; Diringer M.N.; Videen T.O.; Hypoperfusion without ischemia surrounding acute intracerebral hemorrhage. J Cereb Blood Flow Metab [http:\/\/dx.doi.org\/10.1097\/00004647-200107000-00005]. [PMID: 11435792].2001,21(7),804-810","journal-title":"J Cereb Blood Flow Metab"},{"key":"ref=61","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1227\/00006123-198804000-00006","volume":"22","author":"Grote E.","year":"1988","unstructured":"Grote E.; Hassler W.; The critical first minutes after subarachnoid hemorrhage. Neurosurgery 1988,22(4),654-661","journal-title":"Neurosurgery"},{"key":"ref=62","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1097\/00006123-199802000-00091","volume":"42","author":"Bederson J.B.","year":"1998","unstructured":"Bederson J.B.; Levy A.L.; Ding W.H.; Acute vasoconstriction after subarachnoid hemorrhage. Neurosurgery 1998,42(2),352-360","journal-title":"Neurosurgery"},{"key":"ref=63","doi-asserted-by":"crossref","first-page":"4159","DOI":"10.1046\/j.1460-9568.1999.00845.x","volume":"11","author":"Bergeron M.","year":"1999","unstructured":"Bergeron M.; Yu A.Y.; Solway K.E.; Semenza G.L.; Sharp F.R.; Induction of Hypoxia-Inducible Factor-1 (HIF-1) and its target genes following focal ischaemia in rat brain. Eur J Neurosci 1999,11(12),4159-4170","journal-title":"Eur J Neurosci"},{"key":"ref=64","doi-asserted-by":"crossref","first-page":"43","DOI":"10.2335\/scs.31.43","volume":"31","author":"Hishikawa T.","year":"2003","unstructured":"Hishikawa T.; Ono S.; Nishiguchi M.; MRNA and protein expression of hypoxia inducible factor-1 in the rat subarachnoid hemorrhage model. Surg Cereb Stroke 2003,31(Suppl.),43-46","journal-title":"Surg Cereb Stroke"},{"key":"ref=65","first-page":"pp 235","author":"Ostrowski R.P.","unstructured":"Ostrowski R.P.; Colohan A.R.T.; Zhang J.H.; Handbook of Neurochemistry and Molecular Neurobiology; ,pp 235-253","journal-title":"Handbook of Neurochemistry and Molecular Neurobiology;"},{"key":"ref=66","doi-asserted-by":"crossref","first-page":"677","DOI":"10.2174\/1871527316666170424114444","volume":"16","author":"Shevtsova E.F.","year":"2017","unstructured":"Shevtsova E.F.; Vinogradova D.V.; Neganova M.E.; Mitochondrial permeability transition pore as a suitable target for neuroprotective agents against Alzheimer\u2019s disease. CNS Neurol Disord Drug Targets 2017,16(6),677-685","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"ref=67","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1523\/JNEUROSCI.20-08-02825.2000","volume":"20","author":"B\u00fcki A.","year":"2000","unstructured":"B\u00fcki A.; Okonkwo D.O.; Wang K.K.; Povlishock J.T.; Cytochrome c release and caspase activation in traumatic axonal injury. J Neurosci 2000,20(8),2825-2834","journal-title":"J Neurosci"},{"key":"ref=68","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1002\/jnr.21160","volume":"85","author":"Tweedie D.","year":"2007","unstructured":"Tweedie D.; Milman A.; Holloway H.W.; Apoptotic and behavioral sequelae of mild brain trauma in mice. J Neurosci Res 2007,85(4),805-815","journal-title":"J Neurosci Res"},{"key":"ref=69","doi-asserted-by":"crossref","first-page":"CNC45","DOI":"10.2217\/cnc-2017-0013","volume":"2","author":"Kim S.","year":"2017","unstructured":"Kim S.; Han S.C.; Gallan A.J.; Hayes J.P.; Neurometabolic indicators of mitochondrial dysfunction in repetitive mild traumatic brain injury. Concussion 2017,2(3),CNC45","journal-title":"Concussion"},{"key":"ref=70","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1126\/science.1102974","volume":"305","author":"Denicourt C.","year":"2004","unstructured":"Denicourt C.; Dowdy S.F.; Medicine. Targeting apoptotic pathways in cancer cells. Science 2004,305(5689),1411-1413","journal-title":"Science"},{"key":"ref=71","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S1474-4422(05)70283-0","volume":"5","author":"Xi G.","year":"2006","unstructured":"Xi G.; Keep R.F.; Hoff J.T.; Mechanisms of brain injury after intracerebral haemorrhage. Lancet Neurol 2006,5(1),53-63","journal-title":"Lancet Neurol"},{"key":"ref=72","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/325253a0","volume":"325","author":"Janzer R.C.","year":"1987","unstructured":"Janzer R.C.; Raff M.C.; Astrocytes induce blood-brain barrier properties in endothelial cells. Nature 1987,325(6101),253-257","journal-title":"Nature"},{"key":"ref=73","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/nn1623","volume":"9","author":"Takano T.","year":"2006","unstructured":"Takano T.; Tian G.F.; Peng W.; Astrocyte-mediated control of cerebral blood flow. Nat Neurosci 2006,9(2),260-267","journal-title":"Nat Neurosci"},{"key":"ref=74","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/1098-1136(200010)32:1<1::AID-GLIA10>3.0.CO;2-W","volume":"32","author":"Anderson C.M.","year":"2000","unstructured":"Anderson C.M.; Swanson R.A.; Astrocyte glutamate transport: Review of properties, regulation, and physiological functions. Glia 2000,32(1),1-14","journal-title":"Glia"},{"key":"ref=75","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2018\/7301623","volume":"2018","author":"Scimemi A.","year":"2018","unstructured":"Scimemi A.; Astrocytes and the warning signs of intracerebral hemorrhagic stroke. Neural Plast 2018,2018,1-11","journal-title":"Neural Plast"},{"key":"ref=76","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.pneurobio.2015.09.008","volume":"144","author":"Liu Z.","year":"2016","unstructured":"Liu Z.; Chopp M.; Astrocytes, therapeutic targets for neuroprotection and neurorestoration in ischemic stroke. Prog Neurobiol 2016,144,103-120","journal-title":"Prog Neurobiol"},{"key":"ref=77","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.neuroscience.2004.09.053","volume":"129","author":"Simard M.","year":"2004","unstructured":"Simard M.; Nedergaard M.; The neurobiology of glia in the context of water and ion homeostasis. Neuroscience 2004,129(4),877-896","journal-title":"Neuroscience"},{"key":"ref=78","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1046\/j.1471-4159.2003.01268.x","volume":"84","author":"Xi G.","year":"2003","unstructured":"Xi G.; Reiser G.; Keep R.F.; The role of thrombin and thrombin receptors in ischemic, hemorrhagic and traumatic brain injury: deleterious or protective? J Neurochem 2003,84(1),3-9","journal-title":"J Neurochem"},{"key":"ref=79","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1038\/35025229","volume":"407","author":"Coughlin S.R.","year":"2000","unstructured":"Coughlin S.R.; Thrombin signalling and protease-activated receptors. Nature 2000,407(6801),258-264","journal-title":"Nature"},{"key":"ref=80","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1111\/j.1471-4159.2011.07436.x","volume":"119","author":"Shavit E.","year":"2011","unstructured":"Shavit E.; Michaelson D.M.; Chapman J.; Anatomical localization of protease-activated receptor-1 and protease-mediated neuroglial crosstalk on peri-synaptic astrocytic endfeet. J Neurochem 2011,119(3),460-473","journal-title":"J Neurochem"},{"key":"ref=81","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/j.pharep.2016.07.005","volume":"68","author":"Bhardwaj M.","year":"2016","unstructured":"Bhardwaj M.; Kumar A.; Neuroprotective mechanism of Coenzyme Q10 (CoQ10) against PTZ induced kindling and associated cognitive dysfunction: Possible role of microglia inhibition. Pharmacol Rep 2016,68(6),1301-1311","journal-title":"Pharmacol Rep"},{"key":"ref=82","author":"Taylor RA","year":"2013","unstructured":"Taylor RA; Sansing LH; Microglial responses after ischemic stroke and intracerebral hemorrhage. Clin Dev Immunol 2013 2013","journal-title":"Clin Dev Immunol 2013"},{"key":"ref=83","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1038\/sj.jcbfm.9600403","volume":"27","author":"Wang J.","year":"2007","unstructured":"Wang J.; Dor\u00e9 S.; Inflammation after intracerebral hemorrhage. J Cereb Blood Flow Metab 2007,27(5),894-908","journal-title":"J Cereb Blood Flow Metab"},{"key":"ref=84","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1161\/STROKEAHA.108.535419","volume":"40","author":"Hanley D.F.","year":"2009","unstructured":"Hanley D.F.; Intraventricular hemorrhage: Severity factor and treatment target in spontaneous intracerebral hemorrhage. Stroke 2009,40(4),1533-1538","journal-title":"Stroke"},{"key":"ref=85","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0140-6736(13)60986-1","volume":"382","author":"Mendelow A.D.","year":"2013","unstructured":"Mendelow A.D.; Gregson B.A.; Rowan E.N.; Murray G.D.; Gholkar A.; Mitchell P.M.; Early surgery versus initial conservative treatment in patients with spontaneous supratentorial lobar intracerebral haematomas (STICH II): A randomised trial. Lancet 2013,382(9890),397-408","journal-title":"Lancet"},{"key":"ref=86","first-page":"89","author":"Lei B.","year":"2014","unstructured":"Lei B.; Sheng H.; Wang H.; Intrastriatal injection of autologous blood or clostridial collagenase as murine models of intracerebral hemorrhage. J Vis Exp 2014(89),89","journal-title":"J Vis Exp"},{"key":"ref=87","first-page":"54","author":"Sansing L.H.","year":"2011","unstructured":"Sansing L.H.; Kasner S.E.; McCullough L.; Agarwal P.; Welsh F.A.; Kariko K.; Autologous blood injection to model spontaneous intracerebral hemorrhage in mice. J Vis Exp 2011(54),54","journal-title":"J Vis Exp"},{"key":"ref=88","author":"Krafft P.R.","year":"2012","unstructured":"Krafft P.R.; Rolland W.B.; Duris K.; Modeling intracerebral hemorrhage in mice: injection of autologous blood or bacterial collagenase. J Vis Exp 2012(67)","journal-title":"J Vis Exp"},{"key":"ref=89","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1161\/01.STR.0000088061.06656.1E","volume":"34","author":"Belayev L.","year":"2003","unstructured":"Belayev L.; Saul I.; Curbelo K.; Experimental intracerebral hemorrhage in the mouse: Histological, behavioral, and hemodynamic characterization of a double-injection model. Stroke 2003,34(9),2221-2227","journal-title":"Stroke"},{"key":"ref=90","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1097\/00004647-200405000-00002","volume":"24","author":"Nakamura T.","year":"2004","unstructured":"Nakamura T.; Xi G.; Hua Y.; Schallert T.; Hoff J.T.; Keep R.F.; Intracerebral hemorrhage in mice: Model characterization and application for genetically modified mice. J Cereb Blood Flow Metab 2004,24(5),487-494","journal-title":"J Cereb Blood Flow Metab"},{"key":"ref=91","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1161\/01.STR.32.1.162","volume":"32","author":"Xi G.","year":"2001","unstructured":"Xi G.; Hua Y.; Keep R.F.; Younger J.G.; Hoff J.T.; Systemic complement depletion diminishes perihematomal brain edema in rats. Stroke 2001,32(1),162-167","journal-title":"Stroke"},{"key":"ref=92","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1080\/01616412.1996.11740456","volume":"18","author":"Deinsberger W.","year":"1996","unstructured":"Deinsberger W.; Vogel J.; Kuschinsky W.; Auer L.M.; B\u00f6ker D.K.; Experimental intracerebral hemorrhage: Description of a double injection model in rats. Neurol Res 1996,18(5),475-477","journal-title":"Neurol Res"},{"key":"ref=93","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3171\/jns.1994.81.1.0093","volume":"81","author":"Yang G.Y.","year":"1994","unstructured":"Yang G.Y.; Betz A.L.; Chenevert T.L.; Brunberg J.A.; Hoff J.T.; Experimental intracerebral hemorrhage: relationship between brain edema, blood flow, and blood-brain barrier permeability in rats. J Neurosurg 1994,81(1),93-102","journal-title":"J Neurosurg"},{"key":"ref=94","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1161\/01.STR.30.11.2472","volume":"30","author":"Hickenbottom S.L.","year":"1999","unstructured":"Hickenbottom S.L.; Grotta J.C.; Strong R.; Denner L.A.; Aronowski J.; Nuclear factor-kappaB and cell death after experimental intracerebral hemorrhage in rats. Stroke 1999,30(11),2472-2477","journal-title":"Stroke"},{"key":"ref=95","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1002\/ana.10160","volume":"51","author":"Felberg R.A.","year":"2002","unstructured":"Felberg R.A.; Grotta J.C.; Shirzadi A.L.; Cell death in experimental intracerebral hemorrhage: The \u201cblack hole\u201d model of hemorrhagic damage. Ann Neurol 2002,51(4),517-524","journal-title":"Ann Neurol"},{"key":"ref=96","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/S0304-3940(00)00971-X","volume":"283","author":"Xue M.","year":"2000","unstructured":"Xue M.; Del Bigio M.R.; Intracerebral injection of autologous whole blood in rats: Time course of inflammation and cell death. Neurosci Lett 2000,283(3),230-232","journal-title":"Neurosci Lett"},{"key":"ref=97","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1161\/STROKEAHA.110.602755","volume":"42","author":"Chen Z.","year":"2011","unstructured":"Chen Z.; Gao C.; Hua Y.; Keep R.F.; Muraszko K.; Xi G.; Role of iron in brain injury after intraventricular hemorrhage. Stroke 2011,42(2),465-470","journal-title":"Stroke"},{"key":"ref=98","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1093\/jnen\/62.11.1154","volume":"62","author":"Xue M.","year":"2003","unstructured":"Xue M.; Balasubramaniam J.; Buist R.J.; Peeling J.; Del Bigio M.R.; Periventricular\/intraventricular hemorrhage in neonatal mouse cerebrum. J Neuropathol Exp Neurol 2003,62(11),1154-1165","journal-title":"J Neuropathol Exp Neurol"},{"key":"ref=99","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/3-211-30714-1_45","volume":"96","author":"Lodhia K.R.","year":"2006","unstructured":"Lodhia K.R.; Shakui P.; Keep R.F.; Hydrocephalus in a rat model of intraventricular hemorrhage. Acta Neurochir Suppl 2006,96,207-211","journal-title":"Acta Neurochir Suppl"},{"key":"ref=100","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/jcbfm.2013.225","volume":"34","author":"Gao F.","year":"2014","unstructured":"Gao F.; Liu F.; Chen Z.; Hua Y.; Keep R.F.; Xi G.; Hydrocephalus after intraventricular hemorrhage: The role of thrombin. J Cereb Blood Flow Metab 2014,34(3),489-494","journal-title":"J Cereb Blood Flow Metab"},{"key":"ref=101","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1161\/01.STR.0000088061.06656.1E","volume":"34","author":"Belayev L.","year":"2003","unstructured":"Belayev L.; Saul I.; Curbelo K.; Experimental intracerebral hemorrhage in the mouse: Histological, behavioral, and hemodynamic characterization of a double-injection model. Stroke 2003,34(9),2221-2227","journal-title":"Stroke"},{"key":"ref=102","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1097\/00004647-200405000-00002","volume":"24","author":"Nakamura T.","year":"2004","unstructured":"Nakamura T.; Xi G.; Hua Y.; Schallert T.; Hoff J.T.; Keep R.F.; Intracerebral hemorrhage in mice: Model characterization and application for genetically modified mice. J Cereb Blood Flow Metab 2004,24(5),487-494","journal-title":"J Cereb Blood Flow Metab"},{"key":"ref=103","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1179\/1743132815Y.0000000067","volume":"37","author":"Liu L.","year":"2015","unstructured":"Liu L.; Wang S.; Xu R.; Experimental intracerebral haemorrhage: description of a semi-coagulated autologous blood model in rats. Neurol Res 2015,37(10),874-879","journal-title":"Neurol Res"},{"key":"ref=104","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/j.jstrokecerebrovasdis.2016.01.025","volume":"25","author":"Tao C.","year":"2016","unstructured":"Tao C.; Zhang R.; Hu X.; A novel brainstem hemorrhage model by autologous blood infusion in rat: White matter injury, magnetic resonance imaging, and neurobehavioral features. J Stroke Cerebrovasc Dis 2016,25(5),1102-1109","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"ref=105","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1080\/01616412.1996.11740456","volume":"18","author":"Deinsberger W.","year":"1996","unstructured":"Deinsberger W.; Vogel J.; Kuschinsky W.; Auer L.M.; B\u00f6ker D.K.; Experimental intracerebral hemorrhage: Description of a double injection model in rats. Neurol Res 1996,18(5),475-477","journal-title":"Neurol Res"},{"key":"ref=106","volume":"9","author":"Zhu W.","year":"2014","unstructured":"Zhu W.; Gao Y.; Chang C.F.; Wan J.R.; Zhu S.S.; Wang J.; Mouse models of intracerebral hemorrhage in ventricle, cortex, and hippocampus by injections of autologous blood or collagenase. PLoS One 2014,9(5)","journal-title":"PLoS One"},{"key":"ref=107","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1038\/sj.jcbfm.9600548","volume":"28","author":"MacLellan C.L.","year":"2008","unstructured":"MacLellan C.L.; Silasi G.; Poon C.C.; Intracerebral hemorrhage models in rat: Comparing collagenase to blood infusion. J Cereb Blood Flow Metab 2008,28(3),516-525","journal-title":"J Cereb Blood Flow Metab"},{"key":"ref=108","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1590\/S1984-82502009000400002","volume":"45","author":"Santos G.C.D.","year":"2009","unstructured":"Santos G.C.D.; Antunes L.M.G.; Santos A.C.D.; Bianchi M.D.L.P.; Coenzyme Q10 and its effects in the treatment of neurodegenerative diseases. Braz J Pharm Sci 2009,45(4),607-618","journal-title":"Braz J Pharm Sci"},{"key":"ref=109","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1517\/13543781003727495","volume":"19","author":"Villalba J.M.","year":"2010","unstructured":"Villalba J.M.; Parrado C.; Santos-Gonzalez M.; Alcain F.J.; Therapeutic use of coenzyme Q10 and coenzyme Q10-related compounds and formulations. Expert Opin Investig Drugs 2010,19(4),535-554","journal-title":"Expert Opin Investig Drugs"},{"key":"ref=110","doi-asserted-by":"crossref","first-page":"466","DOI":"10.4103\/0975-7406.84471","volume":"3","author":"Saini R.","year":"2011","unstructured":"Saini R.; Coenzyme Q10: The essential nutrient. J Pharm Bioallied Sci 2011,3(3),466-467","journal-title":"J Pharm Bioallied Sci"},{"key":"ref=111","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1523\/JNEUROSCI.22-05-01592.2002","volume":"22","author":"Ferrante R.J.","year":"2002","unstructured":"Ferrante R.J.; Andreassen O.A.; Dedeoglu A.; Therapeutic effects of coenzyme Q10 and remacemide in transgenic mouse models of Huntington\u2019s disease. J Neurosci 2002,22(5),1592-1599","journal-title":"J Neurosci"},{"key":"ref=112","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0304-3940(03)00185-X","volume":"341","author":"M\u00fcller T.","year":"2003","unstructured":"M\u00fcller T.; B\u00fcttner T.; Gholipour A.F.; Kuhn W.; Coenzyme Q10 supplementation provides mild symptomatic benefit in patients with Parkinson\u2019s disease. Neurosci Lett 2003,341(3),201-204","journal-title":"Neurosci Lett"},{"key":"ref=113","doi-asserted-by":"crossref","first-page":"641","DOI":"10.2174\/18715273113129990071","volume":"12","author":"Salama M.","year":"2013","unstructured":"Salama M.; Murillo-Rodr\u00edguez E.; Co-enzyme Q10 to treat neurological disorders: Basic mechanisms, clinical outcomes, and future research direction. CNS Neurol Disord Drug Targets 2013,12(5),641-664","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"ref=114","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.yebeh.2011.09.018","volume":"22","author":"Tawfik M.K.","year":"2011","unstructured":"Tawfik M.K.; Coenzyme Q10 enhances the anticonvulsant effect of phenytoin in pilocarpine-induced seizures in rats and ameliorates phenytoin-induced cognitive impairment and oxidative stress. Epilepsy Behav 2011,22(4),671-677","journal-title":"Epilepsy Behav"},{"key":"ref=115","first-page":"105","volume":"13","author":"Ely J.T.","year":"1998","unstructured":"Ely J.T.; Fudenberg H.H.; Bliznakov E.G.; Branch J.D.; Hemorrhagic stroke in human pretreated with coenzyme Q10: Exceptional recovery as seen in animal models. J Orthomol Med 1998,13(2),105-109","journal-title":"J Orthomol Med"},{"key":"ref=116","author":"Langsjoen P.H.","year":"1995","unstructured":"Langsjoen P.H.; Introduction to Coenzyme Q10 Available from: 1995","journal-title":"Introduction to Coenzyme Q10"},{"key":"ref=117","doi-asserted-by":"crossref","first-page":"44","DOI":"10.3389\/fphys.2018.00044","volume":"9","author":"Hern\u00e1ndez-Camacho J.D.","year":"2018","unstructured":"Hern\u00e1ndez-Camacho J.D.; Bernier M.; L\u00f3pez-Lluch G.; Navas P.; Coenzyme Q10 supplementation in aging and disease. Front Physiol 2018,9,44","journal-title":"Front Physiol"},{"key":"ref=118","doi-asserted-by":"crossref","first-page":"268","DOI":"10.3945\/ajcn.112.040741","volume":"97","author":"Fotino A.D.","year":"2013","unstructured":"Fotino A.D.; Thompson-Paul A.M.; Bazzano L.A.; Effect of coenzyme Q supplementation on heart failure: A meta-analysis. Am J Clin Nutr 2013,97(2),268-275","journal-title":"Am J Clin Nutr"},{"key":"ref=119","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.jchf.2014.06.008","volume":"2","author":"Mortensen S.A.","year":"2014","unstructured":"Mortensen S.A.; Rosenfeldt F.; Kumar A.; The effect of coenzyme Q10 on morbidity and mortality in chronic heart failure: Results from Q-SYMBIO: A randomized double-blind trial. JACC Heart Fail 2014,2(6),641-649","journal-title":"JACC Heart Fail"},{"key":"ref=120","first-page":"1065","volume":"72","author":"Bonakdar R.A.","year":"2005","unstructured":"Bonakdar R.A.; Guarneri E.; Coenzyme Q10. Am Fam Physician 2005,72(6),1065-1070","journal-title":"Am Fam Physician"},{"key":"ref=121","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.nut.2018.05.020","volume":"57","author":"L\u00f3pez-Lluch G.","year":"2019","unstructured":"L\u00f3pez-Lluch G.; Del Pozo-Cruz J.; S\u00e1nchez-Cuesta A.; Cort\u00e9s-Rodr\u00edguez A.B.; Navas P.; Bioavailability of coenzyme Q10 supplements depends on carrier lipids and solubilization. Nutrition 2019,57,133-140","journal-title":"Nutrition"},{"key":"ref=122","first-page":"1065","volume":"72","author":"Bonakdar R.A.","year":"2005","unstructured":"Bonakdar R.A.; Guarneri E.; Coenzyme Q10. Am Fam Physician 2005,72(6),1065-1070","journal-title":"Am Fam Physician"},{"key":"ref=123","first-page":"19","volume":"48","year":"2006","unstructured":"Med Lett Drugs Ther Coenzyme Q102006,48(1229),19-20","journal-title":"Med Lett Drugs Ther"},{"key":"ref=124","doi-asserted-by":"crossref","first-page":"776","DOI":"10.3109\/00207454.2013.801844","volume":"123","author":"Sanoobar M.","year":"2013","unstructured":"Sanoobar M.; Eghtesadi S.; Azimi A.; Khalili M.; Jazayeri S.; Reza G.M.; Coenzyme Q10 supplementation reduces oxidative stress and increases antioxidant enzyme activity in patients with relapsing-remitting multiple sclerosis. Int J Neurosci 2013,123(11),776-782","journal-title":"Int J Neurosci"},{"key":"ref=125","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1167\/iovs.13-12564","volume":"55","author":"Lee D.","year":"2014","unstructured":"Lee D.; Shim M.S.; Kim K.Y.; Coenzyme Q10 inhibits glutamate excitotoxicity and oxidative stress-mediated mitochondrial alteration in a mouse model of glaucoma. Invest Ophthalmol Vis Sci 2014,55(2),993-1005","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref=126","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1161\/STROKEAHA.115.009099","volume":"46","author":"Doll D.N.","year":"2015","unstructured":"Doll D.N.; Hu H.; Sun J.; Lewis S.E.; Simpkins J.W.; Ren X.; Mitochondrial crisis in cerebrovascular endothelial cells opens the blood-brain barrier. Stroke 2015,46(6),1681-1689","journal-title":"Stroke"},{"key":"ref=127","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.tox.2017.06.011","volume":"391","author":"Rose J.","year":"2017","unstructured":"Rose J.; Brian C.; Woods J.; Mitochondrial dysfunction in glial cells: Implications for neuronal homeostasis and survival. Toxicology 2017,391,109-115","journal-title":"Toxicology"},{"key":"ref=128","doi-asserted-by":"crossref","first-page":"268","DOI":"10.3389\/fphar.2015.00268","volume":"6","author":"Singh A.","year":"2015","unstructured":"Singh A.; Kumar A.; Microglial inhibitory mechanism of coenzyme Q10 against A\u03b2 (1-42) induced cognitive dysfunctions: Possible behavioral, biochemical, cellular, and histopathological alterations. Front Pharmacol 2015,6,268","journal-title":"Front Pharmacol"},{"key":"ref=129","doi-asserted-by":"crossref","DOI":"10.1093\/biohorizons\/hzw014","volume":"9","author":"Hawking ZL","year":"2016","unstructured":"Hawking ZL; Alzheimer's disease: The role of mitochondrial dysfunction and potential new therapies. Biosci Horiz: Int J Stud Res 2016,9","journal-title":"Biosci Horiz: Int J Stud Res"},{"key":"ref=130","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1212\/WNL.50.3.793","volume":"50","author":"Shults C.W.","year":"1998","unstructured":"Shults C.W.; Beal M.F.; Fontaine D.; Nakano K.; Haas R.H.; Absorption, tolerability, and effects on mitochondrial activity of oral coenzyme Q10 in parkinsonian patients. Neurology 1998,50(3),793-795","journal-title":"Neurology"},{"key":"ref=131","doi-asserted-by":"crossref","first-page":"309","DOI":"10.4103\/ijp.IJP_11_18","volume":"50","author":"Mehan S.","year":"2018","unstructured":"Mehan S.; Monga V.; Rani M.; Dudi R.; Ghimire K.; Neuroprotective effect of solanesol against 3-nitropropionic acid-induced Huntington\u2019s disease-like behavioral, biochemical, and cellular alterations: Restoration of coenzyme-Q10-mediated mitochondrial dysfunction. Indian J Pharmacol 2018,50(6),309-319","journal-title":"Indian J Pharmacol"},{"key":"ref=132","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1523\/JNEUROSCI.22-05-01592.2002","volume":"22","author":"Ferrante R.J.","year":"2002","unstructured":"Ferrante R.J.; Andreassen O.A.; Dedeoglu A.; Therapeutic effects of coenzyme Q10 and remacemide in transgenic mouse models of Huntington\u2019s disease. J Neurosci 2002,22(5),1592-1599","journal-title":"J Neurosci"},{"key":"ref=133","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1016\/j.neuropharm.2008.08.033","volume":"55","author":"Abdin A.A.","year":"2008","unstructured":"Abdin A.A.; Hamouda H.E.; Mechanism of the neuroprotective role of coenzyme Q10 with or without L-dopa in rotenone-induced parkinsonism. Neuropharmacology 2008,55(8),1340-1346","journal-title":"Neuropharmacology"},{"key":"ref=134","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/S0076-6879(04)82027-5","volume":"382","author":"Sharma S.","year":"2004","unstructured":"Sharma S.; Kheradpezhou M.; Shavali S.; Neuroprotective actions of coenzyme Q10 in Parkinson\u2019s disease. Methods Enzymol 2004,382,488-509","journal-title":"Methods Enzymol"},{"key":"ref=135","author":"Facecchia K.","year":"2012","unstructured":"Facecchia K.; Pre-clinical evaluation of water-soluble coenzyme q10 for therapeutic treatment of Parkinson\u2019s disease. Thesis: University of Windsor 2012","journal-title":"Thesis: University of Windsor"},{"key":"ref=136","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1097\/FBP.0000000000000342","volume":"29","author":"Attia H.N.","year":"2018","unstructured":"Attia H.N.; Maklad Y.A.; Neuroprotective effects of coenzyme Q10 on paraquat-induced Parkinson\u2019s disease in experimental animals. Behav Pharmacol 2018,29(1),79-86","journal-title":"Behav Pharmacol"},{"key":"ref=137","volume":"3","author":"Janzade A","year":"2014","unstructured":"Janzade A; Jameie SB; Choobchian S; Nasirinezhad F; Neuroprotective effect of coenzyme Q10 in chronic constriction injury-induced neuropathic pain in rats. Thrita 2014,3(1)","journal-title":"Thrita"},{"key":"ref=138","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1111\/fcp.12003","volume":"27","author":"Kandhare A.D.","year":"2013","unstructured":"Kandhare A.D.; Ghosh P.; Ghule A.E.; Bodhankar S.L.; Elucidation of molecular mechanism involved in neuroprotective effect of Coenzyme Q10 in alcohol-induced neuropathic pain. Fundam Clin Pharmacol 2013,27(6),603-622","journal-title":"Fundam Clin Pharmacol"},{"key":"ref=139","doi-asserted-by":"crossref","DOI":"10.5812\/ircmj.30297","volume":"18","author":"Sakhaie M.H.","year":"2016","unstructured":"Sakhaie M.H.; Soleimani M.; Pirhajati V.; Soleimani Asl S.; Madjd Z.; Mehdizadeh M.; Coenzyme Q10 ameliorates trimethyltin chloride neurotoxicity in experimental model of injury in dentate gyrus of hippocampus: A histopathological and behavioral study. Iran Red Crescent Med J 2016,18(8)","journal-title":"Iran Red Crescent Med J"},{"key":"ref=140","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s12031-007-9033-7","volume":"34","author":"Yang X.","year":"2008","unstructured":"Yang X.; Yang Y.; Li G.; Wang J.; Yang E.S.; Coenzyme Q10 attenuates \u03b2-amyloid pathology in the aged transgenic mice with Alzheimer presenilin 1 mutation. J Mol Neurosci 2008,34(2),165-171","journal-title":"J Mol Neurosci"},{"key":"ref=141","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1007\/s12031-009-9297-1","volume":"41","author":"Yang X.","year":"2010","unstructured":"Yang X.; Dai G.; Li G.; Yang E.S.; Coenzyme Q10 reduces \u03b2-amyloid plaque in an APP\/PS1 transgenic mouse model of Alzheimer\u2019s disease. J Mol Neurosci 2010,41(1),110-113","journal-title":"J Mol Neurosci"},{"key":"ref=142","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/1471-2202-12-75","volume":"12","author":"Kalayci M.","year":"2011","unstructured":"Kalayci M.; Unal M.M.; Gul S.; Effect of coenzyme Q10 on ischemia and neuronal damage in an experimental traumatic brain-injury model in rats. BMC Neurosci 2011,12(1),75","journal-title":"BMC Neurosci"},{"key":"ref=143","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1212\/WNL.50.3.793","volume":"50","author":"Shults C.W.","year":"1998","unstructured":"Shults C.W.; Beal M.F.; Fontaine D.; Nakano K.; Haas R.H.; Absorption, tolerability, and effects on mitochondrial activity of oral coenzyme Q10 in parkinsonian patients. Neurology 1998,50(3),793-795","journal-title":"Neurology"},{"key":"ref=144","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1001\/archneur.59.10.1541","volume":"59","author":"Shults C.W.","year":"2002","unstructured":"Shults C.W.; Oakes D.; Kieburtz K.; Effects of coenzyme Q10 in early Parkinson disease: Evidence of slowing of the functional decline. Arch Neurol 2002,59(10),1541-1550","journal-title":"Arch Neurol"},{"key":"ref=145","doi-asserted-by":"crossref","first-page":"45","DOI":"10.2174\/1871527314666150821103306","volume":"15","author":"Negida A.","year":"2016","unstructured":"Negida A.; Menshawy A.; Coenzyme Q10 for patients with parkinson\u2019s disease: A systematic review and meta-analysis. CNS Neurol Disord Drug Targets 2016,15(1),45-53","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"ref=146","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1001\/archneur.60.8.1170-b","volume":"60","author":"Horstink M.W.","year":"2003","unstructured":"Horstink M.W.; van Engelen B.G.; The effect of coenzyme Q10 therapy in Parkinson disease could be symptomatic. Arch Neurol 2003,60(8),1170-1172","journal-title":"Arch Neurol"},{"key":"ref=147","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s10072-016-2757-9","volume":"38","author":"Zhu Z.G.","year":"2017","unstructured":"Zhu Z.G.; Sun M.X.; Zhang W.L.; Wang W.W.; Jin Y.M.; Xie C.L.; The efficacy and safety of coenzyme Q10 in Parkinson\u2019s disease: A meta-analysis of randomized controlled trials. Neurol Sci 2017,38(2),215-224","journal-title":"Neurol Sci"},{"key":"ref=148","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1159\/000377676","volume":"73","author":"Li Z.","year":"2015","unstructured":"Li Z.; Wang P.; Yu Z.; The effect of creatine and coenzyme q10 combination therapy on mild cognitive impairment in Parkinson\u2019s disease. Eur Neurol 2015,73(3-4),205-211","journal-title":"Eur Neurol"},{"key":"ref=149","first-page":"397","volume":"57","year":"2001","unstructured":"A randomized, placebo-controlled trial of coenzyme Q10 and remacemide in Huntington\u2019s disease. Neurology 2001,57(3),397-404","journal-title":"Neurology"},{"key":"ref=150","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1212\/01.wnl.0000187070.35365.d7","volume":"65","author":"Ferrante K.L.","year":"2005","unstructured":"Ferrante K.L.; Shefner J.; Zhang H.; Tolerance of high-dose (3,000 mg\/day) coenzyme Q10 in ALS. Neurology 2005,65(11),1834-1836","journal-title":"Neurology"},{"key":"ref=151","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/ana.21743","volume":"66","author":"Kaufmann P.","year":"2009","unstructured":"Kaufmann P.; Thompson J.L.P.; Levy G.; Phase II trial of CoQ10 for ALS finds insufficient evidence to justify phase III. Ann Neurol 2009,66(2),235-244","journal-title":"Ann Neurol"},{"key":"ref=152","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1055\/s-0036-1581995","volume":"36","author":"Saulle M.F.","year":"2016","unstructured":"Saulle M.F.; Schambra H.M.; Recovery and rehabilitation after intracerebral hemorrhage. Semin Neurol 2016,36(3),306-312","journal-title":"Semin Neurol"},{"key":"ref=153","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1097\/00003246-200103000-00031","volume":"29","author":"Diringer M.N.","year":"2001","unstructured":"Diringer M.N.; Edwards D.F.; Admission to a neurologic\/ neurosurgical intensive care unit is associated with reduced mortality rate after intracerebral hemorrhage. Crit Care Med 2001,29(3),635-640","journal-title":"Crit Care Med"},{"key":"ref=154","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1136\/svn-2016-000047","volume":"2","author":"Dastur C.K.","year":"2017","unstructured":"Dastur C.K.; Yu W.; Current management of spontaneous intracerebral haemorrhage. Stroke Vasc Neurol 2017,2(1),21-29","journal-title":"Stroke Vasc Neurol"},{"key":"ref=155","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s12028-008-9057-z","volume":"9","author":"Liu-Deryke X.","year":"2008","unstructured":"Liu-Deryke X.; Janisse J.; Coplin W.M.; Parker D.; Norris G.; Rhoney D.H.; A comparison of nicardipine and labetalol for acute hypertension management following stroke. Neurocrit Care 2008,9(2),167-176","journal-title":"Neurocrit Care"},{"key":"ref=156","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1001\/jamaneurol.2014.1210","volume":"71","author":"Yaghi S.","year":"2014","unstructured":"Yaghi S.; Eisenberger A.; Willey J.Z.; Symptomatic intracerebral hemorrhage in acute ischemic stroke after thrombolysis with intravenous recombinant tissue plasminogen activator: A review of natural history and treatment. JAMA Neurol 2014,71(9),1181-1185","journal-title":"JAMA Neurol"},{"key":"ref=157","first-page":"701","volume":"3","author":"Sahni R.","year":"2007","unstructured":"Sahni R.; Weinberger J.; Management of intracerebral hemorrhage. Vasc Health Risk Manag 2007,3(5),701-709","journal-title":"Vasc Health Risk Manag"},{"key":"ref=158","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1592\/phco.31.11.1085","volume":"31","author":"Wrotek S.E.","year":"2011","unstructured":"Wrotek S.E.; Kozak W.E.; Hess D.C.; Fagan S.C.; Treatment of fever after stroke: Conflicting evidence. Pharmacotherapy 2011,31(11),1085-1091","journal-title":"Pharmacotherapy"},{"key":"ref=159","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s40560-018-0288-6","volume":"6","author":"Yerram S.","year":"2018","unstructured":"Yerram S.; Katyal N.; Premkumar K.; Nattanmai P.; Newey C.R.; Seizure prophylaxis in the neuroscience intensive care unit. J Intensive Care 2018,6(1),17","journal-title":"J Intensive Care"},{"key":"ref=160","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1471-2261-5-24","volume":"5","author":"van Breda E.J.","year":"2005","unstructured":"van Breda E.J.; van der Worp H.B.; van Gemert H.M.A.; PAIS: Paracetamol (acetaminophen) in stroke; protocol for a randomized, double blind clinical trial. BMC Cardiovasc Disord [ISCRTN 74418480]2005,5(1),24","journal-title":"BMC Cardiovasc Disord"},{"key":"ref=161","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1097\/01.WCB.0000130866.25040.7D","volume":"24","author":"Chu K.","year":"2004","unstructured":"Chu K.; Jeong S.W.; Jung K.H.; Celecoxib induces functional recovery after intracerebral hemorrhage with reduction of brain edema and perihematomal cell death. J Cereb Blood Flow Metab 2004,24(8),926-933","journal-title":"J Cereb Blood Flow Metab"},{"key":"ref=162","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.neulet.2006.10.050","volume":"411","author":"Sinn D.I.","year":"2007","unstructured":"Sinn D.I.; Lee S.T.; Chu K.; Combined neuroprotective effects of celecoxib and memantine in experimental intracerebral hemorrhage. Neurosci Lett 2007,411(3),238-242","journal-title":"Neurosci Lett"},{"key":"ref=163","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/1742-2094-10-45","volume":"10","author":"Kaizaki A.","year":"2013","unstructured":"Kaizaki A.; Tien L.T.; Pang Y.; Celecoxib reduces brain dopaminergic neuronaldysfunction, and improves sensorimotor behavioral performance in neonatal rats exposed to systemic lipopolysaccharide. J Neuroinflammation 2013,10(1),45","journal-title":"J Neuroinflammation"},{"key":"ref=164","first-page":"234","volume":"50","author":"Adrianto Y.","year":"2014","unstructured":"Adrianto Y.; Susilo H.; Comparison of functional improvement scale (Nihss) degree between acute intracerebral hemorrhage stroke patients receiving standard treatment and those receiving standard treatment plus celecoxib. Folia MedicaIndonesiana 2014,50(4),234","journal-title":"Folia MedicaIndonesiana"},{"key":"ref=165","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jns.2008.12.020","volume":"279","author":"Park H.K.","year":"2009","unstructured":"Park H.K.; Lee S.H.; Chu K.; Roh J.K.; Effects of celecoxib on volumes of hematoma and edema in patients with primary intracerebral hemorrhage. J Neurol Sci 2009,279(1-2),43-46","journal-title":"J Neurol Sci"},{"key":"ref=166","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1111\/ene.12140","volume":"20","author":"Lee S.H.","year":"2013","unstructured":"Lee S.H.; Park H.K.; Ryu W.S.; Effects of celecoxib on hematoma and edema volumes in primary intracerebral hemorrhage: A multicenter randomized controlled trial. Eur J Neurol 2013,20(8),1161-1169","journal-title":"Eur J Neurol"},{"key":"ref=167","volume":"12","author":"Song Y.","year":"2017","unstructured":"Song Y.; Jun J.H.; Shin E.J.; Kwak Y.L.; Shin J.S.; Shim J.K.; Effect of pregabalin administration upon reperfusion in a rat model of hyperglycemic stroke: Mechanistic insights associated with high-mobility group box 1. PLoS One 2017,12(2)","journal-title":"PLoS One"},{"key":"ref=168","doi-asserted-by":"crossref","first-page":"813","DOI":"10.12659\/MSM.893887","volume":"21","author":"Calikoglu C.","year":"2015","unstructured":"Calikoglu C.; Aytekin H.; Akg\u00fcl O.; Effect of pregabalin in preventing secondary damage in traumatic brain injury: An experimental study. Med Sci Monit 2015,21,813-820","journal-title":"Med Sci Monit"},{"key":"ref=169","doi-asserted-by":"crossref","first-page":"221","DOI":"10.5152\/balkanmedj.2015.15742","volume":"33","author":"A\u015fc\u0131 S.","year":"2016","unstructured":"A\u015fc\u0131 S.; Demirci S.; A\u015fc\u0131 H.; Do\u011fu\u00e7 D.K.; Onaran \u0130.; Neuroprotective effects of pregabalin on cerebral ischemia and reperfusion. Balkan Med J 2016,33(2),221-227","journal-title":"Balkan Med J"},{"key":"ref=170","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.pain.2005.02.032","volume":"115","author":"Freynhagen R.","year":"2005","unstructured":"Freynhagen R.; Strojek K.; Griesing T.; Whalen E.; Balkenohl M.; Efficacy of pregabalin in neuropathic pain evaluated in a 12-week, randomised, double-blind, multicentre, placebo-controlled trial of flexible- and fixed-dose regimens. Pain 2005,115(3),254-263","journal-title":"Pain"},{"key":"ref=171","doi-asserted-by":"crossref","first-page":"222","DOI":"10.5530\/jyp.2018.10.49","volume":"10","author":"Rahajeng B.","year":"2018","unstructured":"Rahajeng B.; Ikawati Z.; Andayani T.M.; Dwiprahasto I.; The effect of pregabalin on the quality of life in patients with central post-stroke pain. J Young Pharmacists 2018,10(2),222","journal-title":"J Young Pharmacists"},{"key":"ref=172","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/sj.jcbfm.9600213","volume":"26","author":"Lee S.T.","year":"2006","unstructured":"Lee S.T.; Chu K.; Jung K.H.; Memantine reduces hematoma expansion in experimental intracerebral hemorrhage, resulting in functional improvement. J Cereb Blood Flow Metab 2006,26(4),536-544","journal-title":"J Cereb Blood Flow Metab"},{"key":"ref=173","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1161\/STROKEAHA.113.004476","volume":"45","author":"L\u00f3pez-Vald\u00e9s H.E.","year":"2014","unstructured":"L\u00f3pez-Vald\u00e9s H.E.; Clarkson A.N.; Ao Y.; Memantine enhances recovery from stroke. Stroke 2014,45(7),2093-2100","journal-title":"Stroke"},{"key":"ref=174","doi-asserted-by":"crossref","first-page":"2774","DOI":"10.1161\/STROKEAHA.112.669374","volume":"43","author":"Montagne A.","year":"2012","unstructured":"Montagne A.; H\u00e9bert M.; Jullienne A.; Memantine improves safety of thrombolysis for stroke. Stroke 2012,43(10),2774-2781","journal-title":"Stroke"},{"key":"ref=175","first-page":"591","volume":"13","author":"Kafi H.","year":"2014","unstructured":"Kafi H.; Salamzadeh J.; Beladimoghadam N.; Sistanizad M.; Kouchek M.; Study of the neuroprotective effects of memantine in patients with mild to moderate ischemic stroke. Iran J Pharm Res 2014,13(2),591-598","journal-title":"Iran J Pharm Res"},{"key":"ref=176","doi-asserted-by":"crossref","first-page":"11","DOI":"10.18869\/acadpub.cjns.1.3.11","volume":"1","author":"Bakhshayesh-Eghbali B.","year":"2015","unstructured":"Bakhshayesh-Eghbali B.; Hajinnori M.; Seyed-Saadat S.M.; Seyed-Saadat S.N.; Kazemnezhad-Leili E.; Rouhi-Rad M.; Comparing the effect of memantine and placebo on clinical outcome of intracranial hemorrhage: A randomized double blind clinical trial. Caspian J Neurol Sci 2015,1(3),11-18","journal-title":"Caspian J Neurol Sci"},{"key":"ref=177","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1161\/01.STR.0000020094.08790.49","volume":"33","author":"Orgogozo J.M.","year":"2002","unstructured":"Orgogozo J.M.; Rigaud A.S.; St\u00f6ffler A.; M\u00f6bius H.J.; Forette F.; Efficacy and safety of memantine in patients with mild to moderate vascular dementia: A randomized, placebo-controlled trial (MMM 300). Stroke 2002,33(7),1834-1839","journal-title":"Stroke"},{"key":"ref=178","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jstrokecerebrovasdis.2010.12.009","volume":"20","author":"Barrett K.M.","year":"2011","unstructured":"Barrett K.M.; Brott T.G.; Brown R.D.; Enhancing recovery after acute ischemic stroke with donepezil as an adjuvant therapy to standard medical care: Results of a phase IIA clinical trial. J Stroke Cerebrovasc Dis 2011,20(3),177-182","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"ref=179","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1080\/026990598122881","volume":"12","author":"Taverni J.P.","year":"1998","unstructured":"Taverni J.P.; Seliger G.; Lichtman S.W.; Donepezil medicated memory improvement in traumatic brain injury during post acute rehabilitation. Brain Inj 1998,12(1),77-80","journal-title":"Brain Inj"},{"key":"ref=180","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/j.apmr.2003.10.014","volume":"85","author":"Zhang L.","year":"2004","unstructured":"Zhang L.; Plotkin R.C.; Wang G.; Sandel M.E.; Lee S.; Cholinergic augmentation with donepezil enhances recovery in short-term memory and sustained attention after traumatic brain injury. Arch Phys Med Rehabil 2004,85(7),1050-1055","journal-title":"Arch Phys Med Rehabil"},{"key":"ref=181","author":"Mayuex R.","year":"1995","unstructured":"Mayuex R.; Chun M.; Acquired and hereditary dementia\u2019s Merritt\u2019 s Textbook of Neurology 1995","journal-title":"Acquired and hereditary dementia\u2019s Merritt\u2019 s Textbook of Neurology"},{"key":"ref=182","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1038\/aps.2015.47","volume":"36","author":"Wang B.F.","year":"2015","unstructured":"Wang B.F.; Cui Z.W.; Zhong Z.H.; Curcumin attenuates brain edema in mice with intracerebral hemorrhage through inhibition of AQP4 and AQP9 expression. Acta Pharmacol Sin 2015,36(8),939-948","journal-title":"Acta Pharmacol Sin"},{"key":"ref=183","volume":"7","author":"Cai J.","year":"2017","unstructured":"Cai J.; Xu D.; Bai X.; Curcumin mitigates cerebral vasospasm and early brain injury following subarachnoid hemorrhage via inhibiting cerebral inflammation. Brain Behav 2017,7(9)","journal-title":"Brain Behav"},{"key":"ref=184","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1097\/ALN.0b013e31823306f0","volume":"115","author":"Kuo C.P.","year":"2011","unstructured":"Kuo C.P.; Lu C.H.; Wen L.L.; Neuroprotective effect of curcumin in an experimental rat model of subarachnoid hemorrhage. Anesthesiology 2011,115(6),1229-1238","journal-title":"Anesthesiology"},{"key":"ref=185","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/sj.cdd.4400476","volume":"6","author":"Porter A.G.","year":"1999","unstructured":"Porter A.G.; J\u00e4nicke R.U.; Emerging roles of caspase-3 in apoptosis. Cell Death Differ 1999,6(2),99-104","journal-title":"Cell Death Differ"},{"key":"ref=186","doi-asserted-by":"crossref","first-page":"62","DOI":"10.2174\/157015910790909485","volume":"8","author":"Bartels A.L.","year":"2010","unstructured":"Bartels A.L.; Leenders K.L.; Cyclooxygenase and neuroinflammation in Parkinson\u2019s disease neurodegeneration. Curr Neuropharmacol 2010,8(1),62-68","journal-title":"Curr Neuropharmacol"},{"key":"ref=187","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1385\/MN:29:2:197","volume":"29","author":"De Simone R.","year":"2004","unstructured":"De Simone R.; Ajmone-Cat M.A.; Minghetti L.; Atypical anti-inflammatory activation of microglia induced by apoptotic neurons: Possible role of phosphatidylserine-phosphatidylserine receptor interaction. Mol Neurobiol 2004,29(2),197-212","journal-title":"Mol Neurobiol"},{"key":"ref=188","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ejphar.2006.09.019","volume":"553","author":"Joshi I.","year":"2006","unstructured":"Joshi I.; Taylor C.P.; Pregabalin action at a model synapse: Binding to presynaptic calcium channel alpha (2)-delta subunit reduces neurotransmission in mice. Eur J Pharmacol 2006,553,82-88","journal-title":"Eur J Pharmacol"},{"key":"ref=189","first-page":"367","volume":"4","author":"Thomas S.J.","year":"2009","unstructured":"Thomas S.J.; Grossberg G.T.; Memantine: A review of studies into its safety and efficacy in treating Alzheimer\u2019s disease and other dementias. Clin Interv Aging 2009,4,367-377","journal-title":"Clin Interv Aging"},{"key":"ref=190","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1517\/14728214.12.3.389","volume":"12","author":"Lapchak P.A.","year":"2007","unstructured":"Lapchak P.A.; Araujo D.M.; Advances in hemorrhagic stroke therapy: Conventional and novel approaches. Expert Opin Emerg Drugs 2007,12(3),389-406","journal-title":"Expert Opin Emerg Drugs"},{"key":"ref=191","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1002\/ana.21597","volume":"65","author":"Berthier M.L.","year":"2009","unstructured":"Berthier M.L.; Green C.; Lara J.P.; Memantine and constraint-induced aphasia therapy in chronic poststroke aphasia. Ann Neurol 2009,65(5),577-585","journal-title":"Ann Neurol"},{"key":"ref=192","first-page":"5","author":"Xu G.Q.","year":"2010","unstructured":"Xu G.Q.; Lan Y.; Ding M.H.; Chen S.Z.; Ding J.X.; Mao Y.R.; Effects of memantine on cognitive impairment of patients with stroke: A randomized, placebo-controlled trial 2010,5","journal-title":"Effects of memantine on cognitive impairment of patients with stroke: A randomized, placebo-controlled trial"},{"key":"ref=193","doi-asserted-by":"crossref","DOI":"10.3171\/2012.1.FOCUS11366","volume":"32","author":"Babu R.","year":"2012","unstructured":"Babu R.; Bagley J.H.; Di C.; Friedman A.H.; Adamson C.; Thrombin and hemin as central factors in the mechanisms of intracerebral hemorrhage-induced secondary brain injury and as potential targets for intervention. Neurosurg Focus 2012,32(4)","journal-title":"Neurosurg Focus"},{"key":"ref=194","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/S1474-4422(08)70165-0","volume":"7","author":"Kalia L.V.","year":"2008","unstructured":"Kalia L.V.; Kalia S.K.; Salter M.W.; NMDA receptors in clinical neurology: excitatory times ahead. Lancet Neurol 2008,7(8),742-755","journal-title":"Lancet Neurol"},{"key":"ref=195","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1602\/neurorx.1.1.101","volume":"1","author":"Lipton S.A.","year":"2004","unstructured":"Lipton S.A.; Failures and successes of NMDA receptor antagonists: molecular basis for the use of open-channel blockers like memantine in the treatment of acute and chronic neurologic insults. NeuroRx 2004,1(1),101-110","journal-title":"NeuroRx"},{"key":"ref=196","doi-asserted-by":"crossref","first-page":"9425","DOI":"10.1523\/JNEUROSCI.2457-04.2004","volume":"24","author":"Shin C.Y.","year":"2004","unstructured":"Shin C.Y.; Kundel M.; Wells D.G.; Rapid, activity-induced increase in tissue plasminogen activator is mediated by metabotropic glutamate receptor-dependent mRNA translation. J Neurosci 2004,24(42),9425-9433","journal-title":"J Neurosci"},{"key":"ref=197","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S1042-3680(18)30643-0","volume":"3","author":"Wityk R.J.","year":"1992","unstructured":"Wityk R.J.; Caplan L.R.; Hypertensive intracerebral hemorrhage. Epidemiology and clinical pathology. Neurosurg Clin N Am 1992,3(3),521-532","journal-title":"Neurosurg Clin N Am"},{"key":"ref=198","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1212\/01.WNL.0000035748.91128.C2","volume":"59","author":"Mayer S.A.","year":"2002","unstructured":"Mayer S.A.; Kreiter K.T.; Copeland D.; Global and domain-specific cognitive impairment and outcome after subarachnoid hemorrhage. Neurology 2002,59(11),1750-1758","journal-title":"Neurology"},{"key":"ref=199","doi-asserted-by":"crossref","first-page":"23","DOI":"10.2340\/16501977-1229","volume":"46","author":"Wallmark S.","year":"2014","unstructured":"Wallmark S.; Ronne-Engstr\u00f6m E.; Lundstr\u00f6m E.; Prevalence of spasticity after aneurysmal subarachnoid haemorrhage. J Rehabil Med 2014,46(1),23-27","journal-title":"J Rehabil Med"},{"key":"ref=200","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/83358","volume":"7","author":"Nicole O.","year":"2001","unstructured":"Nicole O.; Docagne F.; Ali C.; The proteolytic activity of tissue-plasminogen activator enhances NMDA receptor-mediated signaling. Nat Med 2001,7(1),59-64","journal-title":"Nat Med"},{"key":"ref=201","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1038\/nm926","volume":"9","author":"Wang X.","year":"2003","unstructured":"Wang X.; Lee S.R.; Arai K.; Lipoprotein receptor-mediated induction of matrix metalloproteinase by tissue plasminogen activator. Nat Med 2003,9(10),1313-1317","journal-title":"Nat Med"},{"key":"ref=202","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/S1474-4422(03)00486-1","volume":"2","author":"Wilcock G.K.","year":"2003","unstructured":"Wilcock G.K.; Memantine for the treatment of dementia. Lancet Neurol 2003,2(8),503-505","journal-title":"Lancet Neurol"},{"key":"ref=203","doi-asserted-by":"crossref","DOI":"10.1682\/JRRD.2003.07.0108","volume":"41","author":"Nadeau S.E.","year":"2004","unstructured":"Nadeau S.E.; Behrman A.L.; Davis S.E.; Donepezil as an adjuvant to constraint-induced therapy for upper-limb dysfunction after stroke: An exploratory randomized clinical trial. J Rehabil Res Dev 2004,41(4)","journal-title":"J Rehabil Res Dev"},{"key":"ref=204","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/j.1749-6632.2002.tb04859.x","volume":"977","author":"Pratt R.D.","year":"2002","unstructured":"Pratt R.D.; Perdomo C.A.; Donepezil-treated patients with probable vascular dementia demonstrate cognitive benefits. Ann N Y Acad Sci 2002,977(1),513-522","journal-title":"Ann N Y Acad Sci"},{"key":"ref=205","doi-asserted-by":"crossref","first-page":"5308","DOI":"10.1002\/anie.201107724","volume":"51","author":"Esatbeyoglu T.","year":"2012","unstructured":"Esatbeyoglu T.; Huebbe P.; Ernst I.M.; Chin D.; Wagner A.E.; Rimbach G.; Curcumin--from molecule to biological function. Angew Chem Int Ed Engl 2012,51(22),5308-5332","journal-title":"Angew Chem Int Ed Engl"},{"key":"ref=206","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/biof.1041","volume":"39","author":"Shishodia S.","year":"2013","unstructured":"Shishodia S.; Molecular mechanisms of curcumin action: Gene expression. Biofactors 2013,39(1),37-55","journal-title":"Biofactors"},{"key":"ref=207","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1007\/s11481-012-9431-7","volume":"8","author":"Jiang T.F.","year":"2013","unstructured":"Jiang T.F.; Zhang Y.J.; Zhou H.Y.; Curcumin ameliorates the neurodegenerative pathology in A53T alpha-synuclein cell model of Parkinson\u2019s disease through the downregulation of mTOR\/p70S6K signaling and the recovery of macroautophagy. J Neuroimmune Pharmacol 2013,8,356-369","journal-title":"J Neuroimmune Pharmacol"},{"key":"ref=208","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1111\/j.1471-4159.2010.06630.x","volume":"113","author":"Laird M.D.","year":"2010","unstructured":"Laird M.D.; Sukumari-Ramesh S.; Swift A.E.; Meiler S.E.; Vender J.R.; Dhandapani K.M.; Curcumin attenuates cerebral edema following traumatic brain injury in mice: A possible role for aquaporin-4? J Neurochem 2010,113(3),637-648","journal-title":"J Neurochem"},{"key":"ref=209","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1007\/s10072-014-1718-4","volume":"35","author":"Dong H.J.","year":"2014","unstructured":"Dong H.J.; Shang C.Z.; Peng D.W.; Curcumin attenuates ischemia-like injury induced IL-1\u03b2 elevation in brain microvascular endothelial cells via inhibiting MAPK pathways and nuclear factor-\u03baB activation. Neurol Sci 2014,35(9),1387-1392","journal-title":"Neurol Sci"},{"key":"ref=210","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1097\/ALN.0b013e31823306f0","volume":"115","author":"Kuo C.P.","year":"2011","unstructured":"Kuo C.P.; Lu C.H.; Wen L.L.; Neuroprotective effect of curcumin in an experimental rat model of subarachnoid hemorrhage. Anesthesiology 2011,115(6),1229-1238","journal-title":"Anesthesiology"},{"key":"ref=211","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1159\/000324328","volume":"31","author":"Badaut J.","year":"2011","unstructured":"Badaut J.; Ashwal S.; Obenaus A.; Aquaporins in cerebrovascular disease: A target for treatment of brain edema? Cerebrovasc Dis 2011,31(6),521-531","journal-title":"Cerebrovasc Dis"},{"key":"ref=212","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.expneurol.2010.01.015","volume":"223","author":"Tang Y.","year":"2010","unstructured":"Tang Y.; Wu P.; Su J.; Xiang J.; Cai D.; Dong Q.; Effects of aquaporin-4 on edema formation following intracerebral hemorrhage. Exp Neurol 2010,223(2),485-495","journal-title":"Exp Neurol"},{"key":"ref=213","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1111\/j.1471-4159.2006.04414.x","volume":"101","author":"Zhao X.","year":"2007","unstructured":"Zhao X.; Zhang Y.; Strong R.; Zhang J.; Grotta J.C.; Aronowski J.; Distinct patterns of intracerebral hemorrhage-induced alterations in NF-kappaB subunit, iNOS, and COX-2 expression. J Neurochem 2007,101(3),652-663","journal-title":"J Neurochem"},{"key":"ref=214","doi-asserted-by":"crossref","first-page":"24995","DOI":"10.1074\/jbc.270.42.24995","volume":"270","author":"Singh S.","year":"1995","unstructured":"Singh S.; Aggarwal B.B.; Activation of transcription factor NF-kappa B is suppressed by curcumin (diferuloylmethane). J Biol Chem 1995,270(42),24995-25000","journal-title":"J Biol Chem"}],"container-title":["CNS &amp; Neurological Disorders - Drug Targets"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/172435","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,20]],"date-time":"2022-09-20T13:52:02Z","timestamp":1663681922000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/172435\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,30]]},"references-count":214,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,8,30]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1871527318666190610101144","relation":{},"ISSN":["1871-5273"],"issn-type":[{"type":"print","value":"1871-5273"}],"subject":[],"published":{"date-parts":[[2019,8,30]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2019-03-23","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-04-22","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-05-07","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-08-30","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}